entX News: December 2024

Big things on the horizon for entX in 2025!

2024 has been a year of foundation-building and milestones for entX, positioning us for a groundbreaking 2025! Here’s a look at some of our great achievements and where we’re headed.

2024 Achievements:

• IsoMedica Launched! We are already hard at work in our labs at SAHMRI, working with key partners to deliver innovation in medical isotope supply.
• Funding Success: entX secured both State and Federal grants to accelerate our path to commercialisation.
• Best in class: Using commercial scale processes to scale its GenX technology to deliver one of the world’s highest recorded betavoltaic power densities.
• Setting up for Growth: entX is raising capital to execute our strategy of delivering commercial solutions to the radiopharmaceutical and Space & Defence sectors in 2025.

Looking Ahead to 2025:

• Team Expansion: We’re adding to the entX family! Opportunities to join a dynamic, innovative team will be announced soon.
• Scaling Up Isotope Supply: Commissioning of our Medical Isotope Production Facility (944m2) under an SA Government ERF grant.
• Building Supply Partnerships: Building on agreements with a focus on delivering on and expanding our supply contracts.
• Seizing a Global Market: entX aims to be a significant contributor to the $40B radiopharmaceutical market, leading the supply of isotopes critical to produce cancer treatments.
• Export Market Development: Developing the US market interest for GenX and RHU into supply agreements.

A big thank you to all our supporters, shareholders, and dedicated staff who have made 2024 a year to remember. Let’s make 2025 even bigger!

Wishing everyone a safe and Merry Christmas and a wonderful holiday break.

Bryn Jones
Managing Director

entX Limited Awarded $2.9 Million CRC-P Grant to Advance Nuclear Medicine Supply Chain 

entX Limited proudly announces receiving a $2.9 million CRC-P grant to advance IsoMedica’s ‘Mines to Medicines’ project, creating a sustainable and sovereign supply chain for lead-212 (Pb-212), a critical isotope for Targeted Alpha Therapy in cancer treatment. Partnering with leading organisations, entX will innovate methods to extract thorium-228 (Pb-212’s precursor) from industrial waste, reducing reliance on reactors and ensuring patient access to life-saving therapies. Discover how this project is shaping the future of nuclear medicine.

Infinity Avionics looks to radioisotopes for space

We are excited to announce our partnership with Infinity Avionics to design and manufacture parts of our Radioisotope Heater Unit (RHU) Demonstrator Payload designed to provide heat to spacecraft to survive the lunar night.

entX Christmas Lunch 2024!

What a fantastic way to wrap up the year with our team at Big Swing Golf at Mile End! Congratulations to Leigh Whicker for taking out the longest drive competition and Scott Edwards for the nearest to the pin competition! 

We found out that many of the team had some hidden sporting talents not only across golf, but dodgeball, underwater bocce, carnival games and more. It was a great way to celebrate everything we’ve achieved in 2024.